$CRXM Gene Biotherapeutics, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Gene Biotherapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Gene Biotherapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Gene Biotherapeutics, Inc. for free.
IRS Number: 840635673
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: CRXM
Company Address: 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO 92121
Phone number: (858) 436-1000
Former name: SUMMA METALS CORP, date of change: 1994-05-03
Former name: CASMYN CORP, date of change: 1994-12-29
Former name: FINTECH INC, date of change: 1994-05-03
Former name: Cadium Therapeutics, Inc., date of change: 2006-01-18
Former name: CARDIUM THERAPEUTICS, INC, date of change: 2006-01-18
Former name: ARIES VENTURES INC, date of change: 2000-05-23
Former name: Taxus Cardium Pharmaceuticals Group Inc., date of change: 2014-03-18
Market Capitalization: $2.88M
Prev close: $0.21
Average Daily Volume: 20,771
Days Low: $0.19
Year Low: $0.01
Year High: $0.36
Gene Biotherapeutics, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2021 | CRXM | Gene Biotherapeuti ... | Jemapete Christopher J | 10% Owner | Buy | P | 0.40 | 200,000 | 80,400 | 4,000,000 | 3.8 M to 4 M (+5.26 %) |
| Mar 18 2021 | CRXM | Gene Biotherapeuti ... | Jemapete Christopher J | 10% Owner | Buy | P | 0.04 | 300,000 | 11,970 | 3,800,000 | 3.5 M to 3.8 M (+8.57 %) |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | LEWIS GERALD J | Director | Option Exercise | J | 0.60 | 50,000 | 30,000 | 110,000 | |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | Gabrielson Edward W | Director | Option Exercise | J | 0.60 | 50,000 | 30,000 | 110,000 | |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | Otremba Lon E | Director | Option Exercise | J | 0.60 | 50,000 | 30,000 | 110,000 | |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | HUTCHISON MURRAY H | Director | Option Exercise | J | 0.60 | 50,000 | 30,000 | 110,000 | |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | Leitch Andrew M | Director | Option Exercise | J | 0.60 | 50,000 | 30,000 | 110,000 | |
| Mar 27 2015 | CRXM | Taxus Cardium Phar ... | REINHARD CHRISTOPHER J | Chief Executive Off ... | Option Exercise | J | 0.60 | 400,000 | 240,000 | 984,475 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | LEWIS GERALD J | Director | Option Exercise | J | 0.80 | 50,000 | 40,000 | 60,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | REINHARD CHRISTOPHER J | Chief Executive Off ... | Option Exercise | J | 0.80 | 548,550 | 438,840 | 548,550 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | HUTCHISON MURRAY H | Director | Option Exercise | J | 0.80 | 50,000 | 40,000 | 60,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | Otremba Lon E | Director | Option Exercise | J | 0.80 | 50,000 | 40,000 | 60,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | Leitch Andrew M | Director | Option Exercise | J | 0.80 | 50,000 | 40,000 | 60,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | Gabrielson Edward W | Director | Option Exercise | J | 0.80 | 50,000 | 40,000 | 60,000 | |
| Mar 04 2014 | CRXM | Taxus Cardium Phar ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | J | 0.80 | 50,000 | 40,000 | 80,000 |